These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 2414507)

  • 1. [Digoxin in the treatment of patients with ventricular disorders of cardiac rhythm].
    Kurbanov RD; Kiiakbaev GK; Khodzhanova TR
    Kardiologiia; 1985 Jul; 25(7):74-7. PubMed ID: 2414507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of ventricular arrhythmias in patients with manifestations of heart failure].
    Kurbanov RD; Kiiakbaev GK
    Kardiologiia; 1987 May; 27(5):31-4. PubMed ID: 3656890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The characteristics of the action of ethacizine and its combination with digoxin and glutamic acid on the hemodynamic indices and myocardial contractile capacity in patients with a heart rhythm disorder].
    Zapevina VV; Poliakova LA; Nikolaeva SA
    Ter Arkh; 1990; 62(9):51-4. PubMed ID: 1980753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anti-arrhythmia and arrhythmogenic actions of digoxin in ventricular rhythm disorders in patients with circulatory insufficiency].
    Vangeli RS; Naumov VG; Blank ML; Sergakova LM; Grigoriants RA
    Ter Arkh; 1987; 59(9):81-6. PubMed ID: 3424196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical study of the antiarrhythmic action of Mexityl in ventricular disorders of the cardiac rhythm].
    Mazur NA; Liakishev AA; Podrid FD; Piotrovskiĭ VK
    Kardiologiia; 1979 Oct; 19(10):17-21. PubMed ID: 91699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum digoxin concentrations during ethmozine antiarrhythmic therapy.
    Kennedy HL; Sprague MK; Redd RM; Wiens RD; Blum RI; Buckingham TA
    Am Heart J; 1986 Apr; 111(4):667-72. PubMed ID: 2420164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of quinidine monotherapy and combined therapy with digoxin on the central hemodynamics in patients with heart rhythm disorders].
    Orlov LL; Glezer MG; Tsintsadze GI; Zaĭchik IL
    Kardiologiia; 1992 Jul; 32(7-8):17-9. PubMed ID: 1487871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Correction of rate and structure of ventricular rhythm in permanent atrial fibrillation: a novel pathogenetic approach].
    Nedostup AV; Blagova OV; Bogdanova EA; Platonova AA
    Kardiologiia; 2004; 44(1):31-8. PubMed ID: 15029146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decisions in the treatment of ventricular ectopic activity.
    Myerburg RJ; Besozzi MC
    JAMA; 1978 Aug; 240(5):476-9. PubMed ID: 77922
    [No Abstract]   [Full Text] [Related]  

  • 10. [Anti-arrhythmia therapy of acute heart rhythm disorders in the early period after heart valve prosthesis].
    Tsyganiĭ AA; Petrova SL; Zaikina LA; Govenko AV; Atamaniuk MIu
    Kardiologiia; 1983 May; 23(5):22-6. PubMed ID: 6192275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ECG of the month. High anxiety. Ventricular ectopic activity.
    Martinez-Lopez JI
    J La State Med Soc; 1989 May; 141(5):5, 7-8. PubMed ID: 2471763
    [No Abstract]   [Full Text] [Related]  

  • 12. [Long-term use of ethacizin in outpatients with ventricular disorders of heart rhythm].
    Shugushev KhKh; Rozenshtraukh LV; Smetnev AS; Ponamarenko EL
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1986; 9(2):16-20. PubMed ID: 2432906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Standard therapy of acute myocardial infarction.--II: Management of arrhythmias].
    Rudolph W; Dirschinger J
    Herz; 1981 Feb; 6(1):14-24. PubMed ID: 6163689
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cardiac arrhythmias. Types and drug therapy (author's transl)].
    Lehmann HU
    MMW Munch Med Wochenschr; 1981 Apr; 123(17):680-6. PubMed ID: 6164919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative study of the effectiveness of several anti-arrhythmia preparations in patients with a frequent extrasystole].
    Ivanova LA; Mazur NA; Pavlova TS; Bugriĭ EM; Dzhishambaev ED
    Kardiologiia; 1986 Aug; 26(8):37-40. PubMed ID: 2429008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experimental and initial clinical experiences with the new class Ib anti-arrhythmia agent barucainide].
    Gülker H; Heuer H; Frenking B; Haverkamp W; Hindricks G; Bozek B; Bremkes C; Asche KD; Witthöft D
    Z Kardiol; 1988 Sep; 77(9):587-94. PubMed ID: 2461620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the efficacy and tolerance of the antiarrhythmic agent transcainide (R 54718).
    Stroobandt R; Bennett PB; Hondeghem LM; Kesteloot H
    Eur J Clin Pharmacol; 1987; 32(5):449-56. PubMed ID: 2441995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Causes and treatment of ventricular arrhythmias].
    Kappenberger L
    Schweiz Med Wochenschr; 1990 Jun; 120(25):941-5. PubMed ID: 1695020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Long-term drug therapy of arrhythmias (with special reference to ventricular tachyarrhythmias].
    Gertsch M
    Schweiz Med Wochenschr; 1984 Jan; 114(3):77-86. PubMed ID: 6199838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lidocaine as an antiarrhythmic Experience in 68 patients.
    Flensted-Jensen E; Sandoe E
    Acta Med Scand; 1969 Apr; 185(4):297-302. PubMed ID: 4185142
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.